Xtant Medical Holdings (XTNT) Capital Expenditures (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Capital Expenditures for 16 consecutive years, with $430000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Capital Expenditures fell 79.56% year-over-year to $430000.0 in Q3 2025; TTM through Sep 2025 was $2.7 million, a 30.1% decrease from a year earlier, with the FY2024 full-year figure at $4.1 million, up 182.49% from the prior year.
• Capital Expenditures was $430000.0 for Q3 2025 at Xtant Medical Holdings, up from $366000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $2.1 million in Q3 2024 and troughed at $223000.0 in Q3 2023.
• A 5-year average of $601842.1 and a median of $484000.0 in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 843.5% in 2024 and tumbled 79.56% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $626000.0 in 2021, then fell by 29.23% to $443000.0 in 2022, then retreated by 18.06% to $363000.0 in 2023, then surged by 85.12% to $672000.0 in 2024, then plunged by 36.01% to $430000.0 in 2025.
• The last three Capital Expenditures figures came in at $430000.0 (Q3 2025), $366000.0 (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.